Kailera Therapeutics, Inc. (KLRA)
12.58
+0.43
(+3.54%)
USD |
NASDAQ |
Nov 03, 16:00
12.58
0.00 (0.00%)
After-Hours: 17:51
Kailera Therapeutics Net Income (Quarterly) : -111.31M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -111.31M |
| March 31, 2026 | -78.86M |
| Date | Value |
|---|---|
| June 30, 2025 | -28.95M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Twist Bioscience Corp. | -35.05M |
| Prime Medicine, Inc. | -42.11M |
| GRAIL, Inc. | -110.25M |
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 111.31M |
| EPS Diluted (Quarterly) | -0.8587 |
| Enterprise Value | 668.36M |
| Earnings Yield | -13.44% |